In this second episode, we delve into iOnctura, an innovative company developing high impact, low disruption therapies that extend health span for patients. Listen as we chat with iOnctura CSO Lars Van der Veen about what to look for in a strategic partner, how our long-standing, unique partnership with iOnctura came to be and the role that strategic alliances and partnerships have played in the success of the company.

Appearing in this episode:

Host: Cristina Martin-Granados, Strategic Alliance Manager, Cancer Research Horizons

Lars Van der Veen, CSO, iOnctura

Lars holds a PhD in chemistry. He is a medicinal chemist with over 20 years of experience in biopharma R&D and delivered multiple clinical candidates and lead compounds for different therapeutic areas including oncology.

Prior to founding iOnctura he has held various positions in project management and project leadership spanning early discovery up to commercial products and dealing with both biologics and small molecules. Lars has previously worked at Solvay Pharmaceuticals, Organon, Boehringer-Ingelheim and Merck.

Host: Cristina Martin-Granados, Strategic Alliance Manager, Cancer Research Horizons.

Useful links: Cancer Research Horizons – our partnerships | iOnctura

Hosted on Acast. See acast.com/privacy for more information.